Everyone in my department was shocked this week when a federal judge halted all funding for stem cell research, including the work I’m doing in combating disease. We had all thought this issue had been settled last year with the new guidelines, so this development was like a predator leaping upon us unawares.
For those of you not in the field, embryonic stem cell holds promise for curing a host of ills such as Parkinson’s and diabetes. We use adult stem cells in our research as well, but at the stage we’re in we need to have a full range of options at our disposal. This ruling not only turns back the clock to where we stood last year, but goes even further. It also denies funding for projects that were allowed by the previous administration.
Thankfully the President is challenging the ruling but if it stands the funding will be halted by the end of September. Yes, that includes my research as well, which goes on until then.
I know I rarely mention my research in this blog, mainly because the developments that take place are ones I reserve for scientific journals. I don’t want competitors stealing my work! Of course, it’s the competition from other countries that are the main beneficiaries of this ruling. I’m sure they’d be delighted to have the playing field for themselves.
Sorry about the rant.